Jones Kristi

CIK 00018438491 companyGAITHERSBURG, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001843849

Recent Transactions

25 trades

Purchase
NexImmune, Inc.
Series A Preferred Stock, par value $0.0001 per share
2024-06-11$0.01/sh+1→ 1 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+300,000→ 30,000 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+161,500→ 161,500 total
Disposition to Issuer
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04−84,207→ 0 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+29,824→ 29,824 total
Disposition to Issuer
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04−18,824→ 0 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+18,824→ 18,824 total
Disposition to Issuer
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04−24,499→ 0 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+24,499→ 24,499 total
Disposition to Issuer
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04−3,715→ 0 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+3,715→ 3,715 total
Disposition to Issuer
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04−456,000→ 0 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+294,500→ 294,500 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+54,383→ 54,383 total
Disposition to Issuer
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04−88,156→ 0 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+88,156→ 88,156 total
Disposition to Issuer
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04−15,743→ 0 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+15,743→ 15,743 total
Award
NexImmune, Inc.
Common Stock
2022-11-26+296,700→ 369,778 total
Award
NexImmune, Inc.
Stock Option (Right to Buy)
2022-04-05+456,000→ 456,000 total
Purchase
NexImmune, Inc.
Common Stock
2022-03-29$3.74/sh+10,000→ 73,078 total
Purchase
NexImmune, Inc.
Common Stock
2021-02-17$17.00/sh+911→ 63,078 total
Conversion
NexImmune, Inc.
Series A Preferred Stock
2021-02-17−14,738→ 0 total
Conversion
NexImmune, Inc.
Common Stock
2021-02-17+14,738→ 62,167 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2021-02-11+84,207→ 235,144 total

Companies

NexImmune, Inc.
Chief Operating Officer

Recent Filings

Address

C/O NEXIMMUNE, INC. 9119 GAITHER ROAD

GAITHERSBURG, MD, 20877

View on SEC.gov